다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
International journal of antimicrobial agents, v.16 no.4, 2000년, pp.473 - 478
Jeljaszewicz, J (National Institute of Hygiene, Medical University of Warsaw, 24 Chocimska, 00-791 Warsaw, Poland) , Mlynarczyk, G (Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland) , Mlynarczyk, A (Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland)
AI-Helper
AbstractGram-positive cocci still predominate as a cause of nosocomial- and community-acquired infections. These organisms frequently reveal a high natural, intrinsic resistance to antimicrobials. Additionally, these bacteria are able to acquire resistance to frequently used drugs rapidly through se...
Blok. Operacyjny. Jeljaszewicz 3-4 49 1998 Current threats of antibiotic resistance in bacteria
Zentbl. Bakteriol. Mlynarczyk 287 277 1998 10.1016/S0934-8840(98)80165-5 Genome in Staphylococcus aureus: a review
Gene Domanski 167 111 1995 10.1016/0378-1119(96)82965-9 Analysis of Staphylococcus aureus genes encoding penicillin-binding protein 4 and an ABC-type transporter
Antimicrob. Agents Chemother. Henze 40 2121 1996 10.1128/AAC.40.9.2121 Penicillin-binding protein 4 overproduction increases beta-lactam resistance in Staphylococcus aureus
Berger-Bachi 158 1997 The Staphylococci in Human Disease Resistance not mediated by beta-lactamase (methicillin resistance)
Chemotherapy Berger-Bachi 42 19 1996 10.1159/000239498 Update on methicillin resistance mechanisms in staphylococci
Mol. Gen. Genet. Berger-Bachi 219 263 1989 10.1007/BF00261186 femA, A best-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization
Microb. Drug Resist. Kopp 2 29 1996 10.1089/mdr.1996.2.29 Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target?
FEMS Microbiol. Lett. Tschierske 153 261 1997 10.1111/j.1574-6968.1997.tb12583.x Lif, the lysostaphin immunity factor, complements FemB in staphylococcal peptidoglycan interpeptide bridge formation
J. Bacteriol. Henze 175 1612 1993 10.1128/jb.175.6.1612-1620.1993 Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus
J. Biol. Chem. Omelas-Soares 268 26268 1993 10.1016/S0021-9258(19)74310-5 The peptidoglycan composition of a Staphylococcus aureus mutant selected for reduced methicillin resistance
J. Biol. Chem. Omelas-Soares 269 27246 1994 10.1016/S0021-9258(18)46975-X Reduced methicillin resistance in a new Staphylococcus aureus transposon mutant that incorporates muramyl dipeptides into the cell wall peptidoglycan
Microb. Drug Res. Wu 5 9 1999 10.1089/mdr.1999.5.9 Mrp a new auxiliary gene essential for optimal expression of methicillin resistance in Staphylococcus aureus
Eur. J. Clin. Microbiol. Infect. Dis. Voss 13 50 1994 10.1007/BF02026127 Methicillin-resistant Staphylococcus aureus in Europe
J. Hosp. Infect. Mlynarczyk 34 151 1996 10.1016/S0195-6701(96)90141-3 Epidemiology of methcillin resistant Staphylococcus aureus in a Warsaw hospital
Antimicrob. Agents Chemother. Chow 41 3 511 1997 10.1128/AAC.41.3.511 A novel gentamicin resistance gene in Enterococcus
Res. Microbiol. Courvalin 150 367 1999 10.1016/S0923-2508(99)80071-0 Combinatorial approach of bacteria to antibiotic resistance
Microb. Drug Res. Fontana 2 2 209 1996 10.1089/mdr.1996.2.209 Intrinsic penicillin resistance in enterococci
J. Bacteriol. Zorzi 178 16 4948 1996 10.1128/jb.178.16.4948-4957.1996 Structure of the low-affinity penicillin-binding protein 5 PBP5 in wild-type and highly penicillin-resistant strains of Enterococcus faecium
Clin. Microbiol. Rev. Woodford 8 585 1995 10.1128/CMR.8.4.585 Current perspectives on glycopeptide resistance
Antimicrob. Agents Chemother. Perichon 41 2016 1997 10.1128/AAC.41.9.2016 VanD-type glycopeptide-resistant Enterococcus faecalis BM4339
Eur. J. Clin. Microbiol. Infect. Dis. Reynolds 8 943 1989 10.1007/BF01967563 Structure, biochemistry and mechanism of action of glycopeptide antibiotics
Gene Arthur 154 87 1995 10.1016/0378-1119(94)00851-I The vanZ gene of Tn1546 from Enterococcus faecalis BM4147 confers resistance to teicoplanin
J. Bacteriol. Arthur 179 97 1997 10.1128/jb.179.1.97-106.1997 The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction
Mol. Microbiol. Baptista 32 1 17 1999 10.1046/j.1365-2958.1999.01308.x Single-cell analysis of glycopeptide resistance gene expression in teicoplanin-resistant mutants of a VanB-type Enterococcus faecalis
J. Bacteriol. Casadewall 181 3644 1999 10.1128/JB.181.12.3644-3648.1999 Characterization of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339
Gene Quintiliani 172 1 1996 10.1016/0378-1119(96)00110-2 Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281
Gene Dudka-Malen 112 53 1992 10.1016/0378-1119(92)90302-6 Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a d-alanine:d-alanine ligase-related protein necessary for vancomycin resistance
Antimicrob. Agents Chemother. Navarro 38 101 1994 10.1128/AAC.38.8.1788 Analysis of genes encoding d-alanine-d-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens
Mol. Microbiol. Arias 31 1653 1999 10.1046/j.1365-2958.1999.01294.x Characterization and modelling of VanT: a novel, membrane bound, serine racemase form vancomycin-resistant Enterococcus galinarum BM4174
Antimicrob. Agents Chemother. Fines 43 2161 1999 10.1128/AAC.43.9.2161 VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405
J. Antimicrob. Chemother. Hiramatsu 40 135 1997 10.1093/jac/40.1.135 Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Lancet Hiramatsu 350 1670 1997 10.1016/S0140-6736(97)07324-8 Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
Antimicrob. Agents Chemother. Milewski 40 166 1996 10.1128/AAC.40.1.166 Overproduction of a 37-kilodalton cytoplasmatic protein homologous to NAD+-linked d-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus
J. Bacteriol. Boyle-Vavra 179 6756 1997 10.1128/jb.179.21.6756-6763.1997 Cloning of the Staphylococcus aureus ddh gene encoding NAD+-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolate
J. Bacteriol. Billot-Klein 179 4684 1997 10.1128/jb.179.15.4684-4688.1997 Presence of UDP-N-acetylmuramyl-hexapeptides and heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin or vancomycin
J. Bacteriol. Sieradzki 179 2557 1997 10.1128/jb.179.8.2557-2566.1997 Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus
Antimicrob. Agents. Chemother. Sieradzki 42 100 1998 10.1128/AAC.42.1.100 Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci
J. Antimicrob. Chemother. Mlynarczyk 39 136 1997 10.1093/jac/40.1.136 Lysogenic conversion as a factor influencing the vancomycin tolerance phenomenon in Staphylococcus aureus
J. Antimicrob. Chemother. May 42 189 1998 10.1093/jac/42.2.189 Glycopeptide tolerance in Staphylococcus aureus
Med. Dosw. Mikrobiol. Mlynarczyk 47 141 1995 Bacteriophages of the serologic group B converting synthesis of fibrinolysin in Staphylococcus aureus
Med. Dosw. Mikrobiol. Mlynarczyk 47 149 1995 Bacteriophages of the serologic group F converting synthesis of fibrinolysin and beta toxin in Staphylococcus aureus
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.